The management and outcomes of fingolimod first dose cardiac monitoring in UK patients with relapsing-remitting multiple sclerosis. [electronic resource]
Producer: 20161024Description: 40-6 p. digitalISSN:- 2211-0356
- Adult
- Blood Pressure -- drug effects
- Cardiovascular Diseases -- chemically induced
- Female
- Fingolimod Hydrochloride -- adverse effects
- Heart Rate -- drug effects
- Humans
- Immunosuppressive Agents -- adverse effects
- Male
- Monitoring, Physiologic
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Retrospective Studies
- Treatment Outcome
- United Kingdom
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.